AIGH Capital Management LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 29, 2025), AIGH Capital Management LLC reported 34 stock positions worth $213.1 million. Its top holding was Personalis (PSNL) at 11.5% of the portfolio, followed by Huckleberry AI (HUCK, 8.8%) and Scpharmaceuticals (SCPH, 6.9%). Compared with Q1 2025, it opened 2 new positions, sold out of 6, added to 13 and reduced 14. The biggest buy was Huckleberry AI (HUCK, shares +78%) and the biggest sale an exit from BK Technologies (BKTI).
- Most Recent 13F
- Q2 2026
- Location
- BALTIMORE, MD
- CIK
- 0001835943
- Portfolio Value
- $213.1M (Q2 2025)
- SEC Filing
- 0001214659-25-011036 ↗ filed Jul 29, 2025
Holdings Value
Holdings 34 stocks · $213.1M
| PSNL Personalis Inc. | 11.46% | 3,723,958 | $24.4M | Reduce -6.2% |
| HUCK Huckleberry AI Inc. filed as DOMO INC | 8.79% | 1,341,518 | $18.7M | Add +78.5% |
| SCPH Scpharmaceuticals Inc. | 6.91% | 3,867,523 | $14.7M | Reduce -5.6% |
| ARQ Arq Inc. | 6.69% | 2,654,486 | $14.3M | Reduce -4.2% |
| VPG Vishay Precision Group | 5.58% | 423,484 | $11.9M | Add +60.7% |
| LASR Nlight Inc. | 5.54% | 600,103 | $11.8M | New |
| LPTH Lightpath Technologies Inc. Class A | 5.26% | 3,642,377 | $11.2M | Reduce -1.1% |
| BLZE Backblaze Inc. Class A | 4.67% | 1,809,096 | $10.0M | Add +5.7% |
| VSTM Verastem Inc. | 3.90% | 2,003,179 | $8.3M | Reduce -14.3% |
| ZVRA Zevra Therapeutics Inc. | 3.80% | 918,893 | $8.1M | Reduce -36.1% |
| MYO Myomo Inc. | 3.60% | 3,555,742 | $7.7M | Add +22.3% |
| ELVA Electrovaya Inc. | 3.45% | 2,155,836 | $7.4M | Reduce -4.7% |
| ALNT Allient Inc. | 3.41% | 200,000 | $7.3M | New |
| ELUT Elutia Inc. | 3.21% | 3,451,025 | $6.8M | Add +2.1% |
| COYA Coya Therapeutics Inc. | 2.98% | 1,105,622 | $6.4M | Reduce -6.6% |
| HRTX Heron Therapeutics Inc. | 2.92% | 3,009,257 | $6.2M | Add +8.3% |
| THTX Theratechnologies Inc. | 2.31% | 2,082,491 | $4.9M | Reduce -10.5% |
| ANGO Angiodynamics Inc. | 2.21% | 474,488 | $4.7M | No change |
| RNXT Renovorx Inc. | 2.14% | 3,467,275 | $4.6M | No change |
| PYPD Polypid Ltd. | 1.98% | 1,194,108 | $4.2M | Add +27.0% |
| FENC Fennec Pharmaceuticals Inc. | 1.76% | 452,400 | $3.8M | Add +25.3% |
| GRCE Grace Therapeutics Inc. | 1.57% | 1,128,497 | $3.4M | Reduce -14.7% |
| IPWR Ideal Power Inc. | 1.42% | 668,623 | $3.0M | Reduce -18.3% |
| AMPG Amplitech Group Inc. | 0.90% | 905,453 | $1.9M | No change |
| KALA Kala Bio Inc. | 0.67% | 300,000 | $1.4M | Add +52.8% |
| NRXS Neuraxis Inc. | 0.45% | 400,000 | $968K | Add +1913.2% |
| APRE Aprea Therapeutics Inc. | 0.43% | 539,300 | $913K | No change |
| IDN Intellicheck Inc. | 0.39% | 154,174 | $831K | Reduce -90.3% |
| BIOMX INC | 0.33% | 1,566,944 | $705K | No change |
| BFRI Biofrontera Inc. | 0.33% | 974,525 | $693K | Add +33.1% |
| KPRX Kiora Pharmaceuticals Inc. | 0.29% | 216,345 | $623K | Reduce -14.7% |
| FKWL Franklin Wireless Corp. | 0.27% | 139,702 | $584K | Reduce -63.8% |
| SMTK Smartkem Inc. | 0.21% | 438,685 | $439K | Add +50.4% |
| INAB IN8BIO Inc. | 0.15% | 149,895 | $313K | Add +158.4% |
Options reported separately and not counted above: GLW calls ($9.2M).
Portfolio Sells Q1 2025 → Q2 2025
| BKTI BK Technologies Corp. | Sold out | 0.00% | −5.46 |
| VSTM Verastem Inc. | Reduce -14.3% | 3.90% | −3.41 |
| AKBA Akebia Therapeutics Inc. | Sold out | 0.00% | −2.91 |
| IDN Intellicheck Inc. | Reduce -90.3% | 0.39% | −2.12 |
| ZVRA Zevra Therapeutics Inc. | Reduce -36.1% | 3.80% | −1.79 |
| DCTH Delcath Systems Inc. | Sold out | 0.00% | −1.72 |
| BDSX Biodesix Inc. | Sold out | 0.00% | −1.39 |
| COYA Coya Therapeutics Inc. | Reduce -6.6% | 2.98% | −0.99 |
| TELA Tela Bio Inc. | Sold out | 0.00% | −0.90 |
| FKWL Franklin Wireless Corp. | Reduce -63.8% | 0.27% | −0.87 |
| IPWR Ideal Power Inc. | Reduce -18.3% | 1.42% | −0.79 |
| APPS Digital Turbine Inc. | Sold out | 0.00% | −0.61 |
| KPRX Kiora Pharmaceuticals Inc. | Reduce -14.7% | 0.29% | −0.10 |
| GRCE Grace Therapeutics Inc. | Reduce -14.7% | 1.57% | +0.01 |
| THTX Theratechnologies Inc. | Reduce -10.5% | 2.31% | +0.62 |
| ARQ Arq Inc. | Reduce -4.2% | 6.69% | +0.70 |
| ELVA Electrovaya Inc. | Reduce -4.7% | 3.45% | +0.73 |
| SCPH Scpharmaceuticals Inc. | Reduce -5.6% | 6.91% | +1.32 |
| LPTH Lightpath Technologies Inc. Class A | Reduce -1.1% | 5.26% | +1.42 |
| PSNL Personalis Inc. | Reduce -6.2% | 11.46% | +4.24 |
Portfolio Buys Q1 2025 → Q2 2025
| HUCK Huckleberry AI Inc. | Add +78.5% | 8.79% | +5.77 |
| LASR Nlight Inc. | New | 5.54% | +5.54 |
| ALNT Allient Inc. | New | 3.41% | +3.41 |
| VPG Vishay Precision Group | Add +60.7% | 5.58% | +2.29 |
| PYPD Polypid Ltd. | Add +27.0% | 1.98% | +0.66 |
| FENC Fennec Pharmaceuticals Inc. | Add +25.3% | 1.76% | +0.62 |
| NRXS Neuraxis Inc. | Add +1913.2% | 0.45% | +0.43 |
| BLZE Backblaze Inc. Class A | Add +5.7% | 4.67% | +0.38 |
| KALA Kala Bio Inc. | Add +52.8% | 0.67% | +0.09 |
| INAB IN8BIO Inc. | Add +158.4% | 0.15% | +0.02 |
| BFRI Biofrontera Inc. | Add +33.1% | 0.33% | +0.02 |
| SMTK Smartkem Inc. | Add +50.4% | 0.21% | −0.24 |
| HRTX Heron Therapeutics Inc. | Add +8.3% | 2.92% | −0.25 |
| ELUT Elutia Inc. | Add +2.1% | 3.21% | −1.23 |
| MYO Myomo Inc. | Add +22.3% | 3.60% | −3.65 |
Options Activity Q1 2025 → Q2 2025
| QQQ Invesco QQQ Trust Series 1 | put | Sold out | 70,000 | $32.8Mbefore exit |
| IWM iShares Russell 2000 ETF | put | Sold out | 40,000 | $8.0Mbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 42 | $1.1B | SNDK, MXL, INTC, APPS, SIMO |
| Q1 2026 | 40 | $488.3M | SNDK, TYGO, SIMO, ZBRA, LASR |
| Q4 2025 | 31 | $338.3M | SNDK, CSTL, PSNL, LASR, DAWN |
| Q3 2025 | 34 | $285.6M | SNDK, PSNL, HUCK, ARQ, MXL |
| Q2 2025 | 34 | $213.1M | PSNL, HUCK, SCPH, ARQ, VPG |
| Q1 2025 | 38 | $192.7M | VSTM, MYO, PSNL, ARQ, SCPH |
| Q4 2024 | 36 | $265.7M | PSNL, MYO, ARQ, DCTH, MRVL |
| Q3 2024 | 37 | $213.6M | PSNL, SCPH, ARQ, DCTH, APPS |
| Q2 2024 | 35 | $204.9M | SIMO, INFN, DCTH, SCPH, ARQ |
| Q1 2024 | 39 | $207.3M | SCPH, OUST, ELVA, CLRB, DCTH |